CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- 4 Planned sale Chief Commercial Officer sold 12,500 shares at an average $128.61 ($1,607,635)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale President, R&D sold 50,000 shares at an average $116.20 ($5,809,889)
- 4 Open-market sale President and CEO sold 50,000 shares at an average $116.20 ($5,809,889)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 4 Planned sale Chief Accounting Officer sold 53,428 shares at an average $101.60 ($5,428,115)
- 4 Planned sale Director sold 50,000 shares at $95.02 ($4,751,185)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 17,100 shares at $90.74 ($1,551,579)
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 424B5 Offering Prospectus
Page 11 of 26 · 513 filings